Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
4,503,909
-
Total 13F shares
-
3,006,006
-
Share change
-
+1,539,765
-
Total reported value
-
$3,849,000
-
Price per share
-
$1.28
-
Number of holders
-
21
-
Value change
-
+$1,971,582
-
Number of buys
-
13
-
Number of sells
-
6
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q2 2020
As of 30 Jun 2020,
Cellectar Biosciences, Inc. - Common Shares (CLRB) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,006,006 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, Worth Venture Partners, LLC, Sio Capital Management, LLC, CVI Holdings, LLC, Quilter Plc, FNY Investment Advisers, LLC, SPHERA FUNDS MANAGEMENT LTD., TWO SIGMA ADVISERS, LP, and WEDBUSH SECURITIES INC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.